3rd Annual Biosimilars & Biobetters Congress 2015

Over 350 biosimilars, proteins and peptides attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Over 20 presentations and case studies focusing on the key areas of the biosimilars industry.

Two-day interactive conference addressing the following topics:

  • Market Access Strategies, Opportunities And Commercial Challenges
  • Developing Biosimilars And Biobetters

Co-located with the 8th Annual Proteins & Antibodies Congress and 2nd Annual Peptides Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 3rd Annual Biosimilars & Biobetters Congress, taking place on the 20th and 21st April 2015 at the Novotel London West, London, UK. The congress is an exclusive opportunity for over 350 biologics experts to exchange their experiences, engage in scientific discussions and debate the best practices and solutions to improve the biosimilars industry performance.

Despite having to overcome tight regulatory, business and financial challenges, the biosimilars industry is forecast to be worth up to $25 billion by 2020. The rapid growth of the industry requires biosimilar experts to be at the forefront of knowledge with the current landscape of the industry.

Day One will explore biosimilars market access strategies, opportunities and commercial challenges. Our esteemed speakers will provide the latest regulatory updates and multiple perspectives on biosimilars. Presentations will also provide an insight into market access initiatives and opportunities in emerging markets, case studies on global commercialisation strategies and evaluating the current market for biosimilars success.

Day Two will focus on biosimilars and biobetters development. Internationally renowned speakers will discuss current challenges and obstacles in the development of biosimilars and the latest solutions to demonstrate biosimilarity. Delegates will also have the opportunity to hear different characterisation methods, industry case studies on biosimilar mAb development and clinical and non-clinical advances in biosimilars.

The 3rd Annual Biosimilars & Biobetters Congress forms part of Oxford Global’s highly successful Biologics Series. For more information on other events in this series, please see the details below:

Proteins & Antibodies, Peptides and Biosimilars & Biobetters Congress 2015 Sponsors:



Media Partners

mnt_logo_whitelr-tagline-425x175remversion_biosimilarnews_logo200The Queen's Awards for Enterprise: International Trade 2010absavepharmavoice200bioportfolio-logo200labsave-logopharmaphorum-logo200clocate_logo_180x60ptf-logo200pharma-logo-high-resbio-equip_logo_www-bio-equip-cn_TechNet Communities(com)textTechNet Communities(com)textiptechex_pharmalicensinglab-bulletin-logonew200biosave-logo